IRIS
MANCARDI, GIOVANNI LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 53.642
AS - Asia 89
SA - Sud America 29
NA - Nord America 3
Totale 53.763
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 53.640
CN - Cina 56
BR - Brasile 25
SG - Singapore 20
VN - Vietnam 9
EC - Ecuador 3
US - Stati Uniti d'America 3
AR - Argentina 1
ID - Indonesia 1
IL - Israele 1
KZ - Kazakistan 1
LB - Libano 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 53.763
Salva come PNG Salva come JPEG
Città #
Genova 35.457
Genoa 11.080
Rapallo 4.076
Vado Ligure 2.943
Bordighera 80
Beijing 24
Singapore 7
Ho Chi Minh City 3
São Paulo 3
Ashburn 2
Guayaquil 2
Hanoi 2
Milan 2
Rome 2
Taboão da Serra 2
Astana 1
Belo Horizonte 1
Brasília 1
Brooklyn 1
Campinas 1
Ceres 1
Contagem 1
Cà Mau 1
Feira de Santana 1
Hải Dương 1
Isidro Casanova 1
Itapevi 1
Itatiba 1
Jacobina 1
Ji Paraná 1
Limoeiro do Norte 1
Loja 1
Magé 1
Na‘an 1
Nova Serrana 1
Perm 1
Pirot 1
Portão 1
Pracinha 1
Recife 1
Registro 1
Thái Bình 1
Thái Nguyên 1
Uberlândia 1
União dos Palmares 1
Vitória da Conquista 1
Totale 53.716
Salva come PNG Salva come JPEG
Nome #
Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS 227
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy 220
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 217
An updated Italian normative dataset for the Stroop color word test (SCWT) 214
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. 209
Dysimmune mononeuropathies: A diagnosis not to be missed 206
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 203
A normative study of the Italian printed word version of the free and cued selective reminding test 198
Neural correlates of ankle movements during different motor tasks: A feasibility study 195
Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis 195
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report. 192
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. 190
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 188
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 187
Basal ganglia are active during motor performance recovery after a demanding motor task. 187
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 186
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption 184
Fast course ALS presenting with vocal cord paralysis: clinical features, bioinformatic and modelling analysis of the novel SOD1 Gly147Ser mutation. 180
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 178
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 177
Clinical epidemiology of ALS in Liguria, Italy. 177
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. 176
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 176
Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine 176
Neural correlates of lower limbs proprioception: An fMRI study of foot position matching 175
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 172
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 171
Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? 171
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 171
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 171
Different MRI patterns in MS worsening after stopping fingolimod 171
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. 169
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. 169
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 168
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 168
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 168
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 168
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 167
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. 167
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 167
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 166
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. 166
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 165
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis 164
Evidence for aerobic ATP synthesis in isolated myelin vesicles 163
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 163
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 163
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 161
An engineered glove for investigating the neural correlates of finger movements using functional magnetic resonance imaging 161
OXCARBAZEPINE FOR TREATING PAROXYSMAL PAINFUL SYMPTOMS IN MULTIPLE SCLEROSIS: A PILOT STUDY. 160
Direct immunofluorescence in sural nerve biopsies. 160
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 160
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 159
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 159
Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. 158
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. 158
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 158
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 158
Neurological research in Italy in 2003 and 2004. 157
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 157
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 157
Three years of experience: the Italian registry and safety data update 157
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 156
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis. 155
A patient with multiple sclerosis and Down's syndrome with a rare paroxysmal symptom at onset. 155
GFAP expression of human Schwann cells in tissue culture. 155
Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis 155
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 154
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 154
Screening, diagnosis, and management of obstructive sleep apnea in dangerous-goods truck drivers: to be aware or not? 154
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 152
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks 152
A prospective study of acute idiopathic neuropathy II antecedent events. 152
Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. 152
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 152
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 152
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 152
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis. 151
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 151
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience. 151
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 151
Primary varicella zoster infection associated with fingolimod treatment. 150
'Apraxia' of eye opening in idiopathic Parkinson's disease. 150
Use of cosH1 probe in hereditary neuropathy with liability to pressure palsies: a reliable genetic test for demonstration of identical size of 17p11.2 deletion in unrelated patients. 150
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. 150
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. 149
Anxiety and depression in multiple sclerosis patients around diagnosis. 149
Growing Region Segmentation Software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: intra- and inter-observer agreement variability: a comparison with manual contouring method. 149
Human mesenchymal stem cells promote survival of T cells in a quiescent state. 149
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 149
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. 147
Clinical features of Sjogren's syndrome in patients with multiple sclerosis. 147
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 147
Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? 147
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 147
The prevalence of multiple sclerosis in the north-west Italian province of Genoa. 146
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. 146
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 146
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. 146
Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis 146
Totale 16.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.276
article - articoli 151.817
book - libri 752
conference - conferenze 12.507
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.200
Totale 332.552
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.520 0 0 0 372 179 256 196 348 291 384 233 261
2021/20225.493 165 399 656 695 170 292 287 1.250 217 494 152 716
2022/20234.881 491 396 58 467 803 858 20 370 854 27 467 70
2023/20242.539 154 340 64 283 190 521 201 152 131 35 122 346
2024/20257.294 248 564 249 465 989 778 631 1.134 324 335 627 950
2025/20263.614 1.593 388 745 888 0 0 0 0 0 0 0 0
Totale 54.321